Anti-Glaucoma Drug Market - Global Outlook and Forecast 2022-2028

January 2022 | 71 pages | ID: A401CC286A9BEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Anti-Glaucoma Drug in Global, including the following market information:

Global Anti-Glaucoma Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti-Glaucoma Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Miosis Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-Glaucoma Drug include Pfizer, Merck, Allergan, Santen, Alcon, Teva Pharmaceuticals, Fera Pharmaceuticals, Bausch & Lomb, Inc. and Akorn, Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Glaucoma Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-Glaucoma Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti-Glaucoma Drug Market Segment Percentages, by Type, 2021 (%)

• Miosis Drugs
• Beta-Blocker
• Adrenergic Agonists
• Carbonic Anhydrase Inhibitor
• Prostaglandin Derivative Agent
• Penetrates

Global Anti-Glaucoma Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti-Glaucoma Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Drugstore
• Online Sales

Global Anti-Glaucoma Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti-Glaucoma Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-Glaucoma Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti-Glaucoma Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Merck
• Allergan
• Santen
• Alcon
• Teva Pharmaceuticals
• Fera Pharmaceuticals
• Bausch & Lomb, Inc.
• Akorn, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-Glaucoma Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-Glaucoma Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-GLAUCOMA DRUG OVERALL MARKET SIZE

2.1 Global Anti-Glaucoma Drug Market Size: 2021 VS 2028
2.2 Global Anti-Glaucoma Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-Glaucoma Drug Players in Global Market
3.2 Top Global Anti-Glaucoma Drug Companies Ranked by Revenue
3.3 Global Anti-Glaucoma Drug Revenue by Companies
3.4 Top 3 and Top 5 Anti-Glaucoma Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-Glaucoma Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Glaucoma Drug Players in Global Market
  3.6.1 List of Global Tier 1 Anti-Glaucoma Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-Glaucoma Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti-Glaucoma Drug Market Size Markets, 2021 & 2028
  4.1.2 Miosis Drugs
  4.1.3 Beta-Blocker
  4.1.4 Adrenergic Agonists
  4.1.5 Carbonic Anhydrase Inhibitor
  4.1.6 Prostaglandin Derivative Agent
  4.1.7 Penetrates
4.2 By Type - Global Anti-Glaucoma Drug Revenue & Forecasts
  4.2.1 By Type - Global Anti-Glaucoma Drug Revenue, 2017-2022
  4.2.2 By Type - Global Anti-Glaucoma Drug Revenue, 2023-2028
  4.2.3 By Type - Global Anti-Glaucoma Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-Glaucoma Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Drugstore
  5.1.4 Online Sales
5.2 By Application - Global Anti-Glaucoma Drug Revenue & Forecasts
  5.2.1 By Application - Global Anti-Glaucoma Drug Revenue, 2017-2022
  5.2.2 By Application - Global Anti-Glaucoma Drug Revenue, 2023-2028
  5.2.3 By Application - Global Anti-Glaucoma Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-Glaucoma Drug Market Size, 2021 & 2028
6.2 By Region - Global Anti-Glaucoma Drug Revenue & Forecasts
  6.2.1 By Region - Global Anti-Glaucoma Drug Revenue, 2017-2022
  6.2.2 By Region - Global Anti-Glaucoma Drug Revenue, 2023-2028
  6.2.3 By Region - Global Anti-Glaucoma Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti-Glaucoma Drug Revenue, 2017-2028
  6.3.2 US Anti-Glaucoma Drug Market Size, 2017-2028
  6.3.3 Canada Anti-Glaucoma Drug Market Size, 2017-2028
  6.3.4 Mexico Anti-Glaucoma Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti-Glaucoma Drug Revenue, 2017-2028
  6.4.2 Germany Anti-Glaucoma Drug Market Size, 2017-2028
  6.4.3 France Anti-Glaucoma Drug Market Size, 2017-2028
  6.4.4 U.K. Anti-Glaucoma Drug Market Size, 2017-2028
  6.4.5 Italy Anti-Glaucoma Drug Market Size, 2017-2028
  6.4.6 Russia Anti-Glaucoma Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Anti-Glaucoma Drug Market Size, 2017-2028
  6.4.8 Benelux Anti-Glaucoma Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti-Glaucoma Drug Revenue, 2017-2028
  6.5.2 China Anti-Glaucoma Drug Market Size, 2017-2028
  6.5.3 Japan Anti-Glaucoma Drug Market Size, 2017-2028
  6.5.4 South Korea Anti-Glaucoma Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Anti-Glaucoma Drug Market Size, 2017-2028
  6.5.6 India Anti-Glaucoma Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti-Glaucoma Drug Revenue, 2017-2028
  6.6.2 Brazil Anti-Glaucoma Drug Market Size, 2017-2028
  6.6.3 Argentina Anti-Glaucoma Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-Glaucoma Drug Revenue, 2017-2028
  6.7.2 Turkey Anti-Glaucoma Drug Market Size, 2017-2028
  6.7.3 Israel Anti-Glaucoma Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti-Glaucoma Drug Market Size, 2017-2028
  6.7.5 UAE Anti-Glaucoma Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Anti-Glaucoma Drug Major Product Offerings
  7.1.4 Pfizer Anti-Glaucoma Drug Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Anti-Glaucoma Drug Major Product Offerings
  7.2.4 Merck Anti-Glaucoma Drug Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 Allergan
  7.3.1 Allergan Corporate Summary
  7.3.2 Allergan Business Overview
  7.3.3 Allergan Anti-Glaucoma Drug Major Product Offerings
  7.3.4 Allergan Anti-Glaucoma Drug Revenue in Global Market (2017-2022)
  7.3.5 Allergan Key News
7.4 Santen
  7.4.1 Santen Corporate Summary
  7.4.2 Santen Business Overview
  7.4.3 Santen Anti-Glaucoma Drug Major Product Offerings
  7.4.4 Santen Anti-Glaucoma Drug Revenue in Global Market (2017-2022)
  7.4.5 Santen Key News
7.5 Alcon
  7.5.1 Alcon Corporate Summary
  7.5.2 Alcon Business Overview
  7.5.3 Alcon Anti-Glaucoma Drug Major Product Offerings
  7.5.4 Alcon Anti-Glaucoma Drug Revenue in Global Market (2017-2022)
  7.5.5 Alcon Key News
7.6 Teva Pharmaceuticals
  7.6.1 Teva Pharmaceuticals Corporate Summary
  7.6.2 Teva Pharmaceuticals Business Overview
  7.6.3 Teva Pharmaceuticals Anti-Glaucoma Drug Major Product Offerings
  7.6.4 Teva Pharmaceuticals Anti-Glaucoma Drug Revenue in Global Market (2017-2022)
  7.6.5 Teva Pharmaceuticals Key News
7.7 Fera Pharmaceuticals
  7.7.1 Fera Pharmaceuticals Corporate Summary
  7.7.2 Fera Pharmaceuticals Business Overview
  7.7.3 Fera Pharmaceuticals Anti-Glaucoma Drug Major Product Offerings
  7.7.4 Fera Pharmaceuticals Anti-Glaucoma Drug Revenue in Global Market (2017-2022)
  7.7.5 Fera Pharmaceuticals Key News
7.8 Bausch & Lomb, Inc.
  7.8.1 Bausch & Lomb, Inc. Corporate Summary
  7.8.2 Bausch & Lomb, Inc. Business Overview
  7.8.3 Bausch & Lomb, Inc. Anti-Glaucoma Drug Major Product Offerings
  7.8.4 Bausch & Lomb, Inc. Anti-Glaucoma Drug Revenue in Global Market (2017-2022)
  7.8.5 Bausch & Lomb, Inc. Key News
7.9 Akorn, Inc.
  7.9.1 Akorn, Inc. Corporate Summary
  7.9.2 Akorn, Inc. Business Overview
  7.9.3 Akorn, Inc. Anti-Glaucoma Drug Major Product Offerings
  7.9.4 Akorn, Inc. Anti-Glaucoma Drug Revenue in Global Market (2017-2022)
  7.9.5 Akorn, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti-Glaucoma Drug Market Opportunities & Trends in Global Market
Table 2. Anti-Glaucoma Drug Market Drivers in Global Market
Table 3. Anti-Glaucoma Drug Market Restraints in Global Market
Table 4. Key Players of Anti-Glaucoma Drug in Global Market
Table 5. Top Anti-Glaucoma Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-Glaucoma Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-Glaucoma Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-Glaucoma Drug Product Type
Table 9. List of Global Tier 1 Anti-Glaucoma Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Glaucoma Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-Glaucoma Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-Glaucoma Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-Glaucoma Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti-Glaucoma Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-Glaucoma Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-Glaucoma Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti-Glaucoma Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-Glaucoma Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-Glaucoma Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-Glaucoma Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-Glaucoma Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-Glaucoma Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-Glaucoma Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-Glaucoma Drug Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Anti-Glaucoma Drug Product Offerings
Table 32. Pfizer Anti-Glaucoma Drug Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Anti-Glaucoma Drug Product Offerings
Table 35. Merck Anti-Glaucoma Drug Revenue (US$, Mn), (2017-2022)
Table 36. Allergan Corporate Summary
Table 37. Allergan Anti-Glaucoma Drug Product Offerings
Table 38. Allergan Anti-Glaucoma Drug Revenue (US$, Mn), (2017-2022)
Table 39. Santen Corporate Summary
Table 40. Santen Anti-Glaucoma Drug Product Offerings
Table 41. Santen Anti-Glaucoma Drug Revenue (US$, Mn), (2017-2022)
Table 42. Alcon Corporate Summary
Table 43. Alcon Anti-Glaucoma Drug Product Offerings
Table 44. Alcon Anti-Glaucoma Drug Revenue (US$, Mn), (2017-2022)
Table 45. Teva Pharmaceuticals Corporate Summary
Table 46. Teva Pharmaceuticals Anti-Glaucoma Drug Product Offerings
Table 47. Teva Pharmaceuticals Anti-Glaucoma Drug Revenue (US$, Mn), (2017-2022)
Table 48. Fera Pharmaceuticals Corporate Summary
Table 49. Fera Pharmaceuticals Anti-Glaucoma Drug Product Offerings
Table 50. Fera Pharmaceuticals Anti-Glaucoma Drug Revenue (US$, Mn), (2017-2022)
Table 51. Bausch & Lomb, Inc. Corporate Summary
Table 52. Bausch & Lomb, Inc. Anti-Glaucoma Drug Product Offerings
Table 53. Bausch & Lomb, Inc. Anti-Glaucoma Drug Revenue (US$, Mn), (2017-2022)
Table 54. Akorn, Inc. Corporate Summary
Table 55. Akorn, Inc. Anti-Glaucoma Drug Product Offerings
Table 56. Akorn, Inc. Anti-Glaucoma Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti-Glaucoma Drug Segment by Type in 2021
Figure 2. Anti-Glaucoma Drug Segment by Application in 2021
Figure 3. Global Anti-Glaucoma Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anti-Glaucoma Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-Glaucoma Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Glaucoma Drug Revenue in 2021
Figure 8. By Type - Global Anti-Glaucoma Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-Glaucoma Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-Glaucoma Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-Glaucoma Drug Revenue Market Share, 2017-2028
Figure 12. US Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-Glaucoma Drug Revenue Market Share, 2017-2028
Figure 16. Germany Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-Glaucoma Drug Revenue Market Share, 2017-2028
Figure 24. China Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-Glaucoma Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-Glaucoma Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-Glaucoma Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Anti-Glaucoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Anti-Glaucoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Allergan Anti-Glaucoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Santen Anti-Glaucoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alcon Anti-Glaucoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Teva Pharmaceuticals Anti-Glaucoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Fera Pharmaceuticals Anti-Glaucoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bausch & Lomb, Inc. Anti-Glaucoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Akorn, Inc. Anti-Glaucoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)